Holders — by stockHoldings — by fund
SECTORAL ASSET MANAGEMENT INC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001274413
$157.4M
disclosed book value
78
positions
13.1%
largest position share
Positions, as of 2026-09-30
top 78 of 78 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | APMDAPNIMED INC | 942,208 | $20.6M | 13.1% |
| 2 | CTNMCONTINEUM THERAPEUTICS | 689,587 | $9.3M | 5.9% |
| 3 | SISHOULDER INNOVATIONS | 430,420 | $8.1M | 5.2% |
| 4 | LLYELI LILLY & CO | 6,664 | $7.7M | 4.9% |
| 5 | JNJJOHNSON & JOHNSON | 22,758 | $6.0M | 3.8% |
| 6 | VRTXVERTEX PHARMA | 7,532 | $3.9M | 2.5% |
| 7 | GILDGILEAD SCIENCES INC | 24,655 | $3.7M | 2.3% |
| 8 | AMGNAMGEN INC | 7,860 | $3.3M | 2.1% |
| 9 | ABBVABBVIE INC | 12,300 | $3.2M | 2% |
| 10 | DXCMDEXCOM INC | 37,231 | $3.2M | 2% |
| 11 | SMMTSUMMIT THERAPEUTICS | 177,180 | $3.0M | 1.9% |
| 12 | RCUSARCUS BIOSCIENCES | 115,933 | $3.0M | 1.9% |
| 13 | MRKMERCK & CO INC | 20,460 | $3.0M | 1.9% |
| 14 | BNTXBIONTECH SE | 30,185 | $3.0M | 1.9% |
| 15 | ORKAORUKA THERAPEUTICS INC | 35,349 | $2.9M | 1.9% |
| 16 | AVTXAVALO THERAPEUTICS INC | 177,294 | $2.7M | 1.7% |
| 17 | INSMINSMED INC | 23,706 | $2.7M | 1.7% |
| 18 | AVBPARRIVENT BIOPHARMA | 87,343 | $2.6M | 1.7% |
| 19 | TNGXTANGO THERAPEUTICS INC | 105,757 | $2.6M | 1.7% |
| 20 | ARGXARGENX SE | 2,676 | $2.6M | 1.6% |
| 21 | IRTCIRHYTHM HOLDINGS INC | 22,570 | $2.6M | 1.6% |
| 22 | ATECALPHATEC HLDGS INC | 246,150 | $2.5M | 1.6% |
| 23 | CBIOCRESCENT BIOPHARMA INC. | 167,600 | $2.4M | 1.6% |
| 24 | BRVEBRAVEHEART BIO INC | 119,743 | $2.4M | 1.5% |
| 25 | ISRGINTUITIVE SURGIC INC | 5,869 | $2.4M | 1.5% |
| 26 | UNHUNITEDHEALTH GRP INC | 6,208 | $2.3M | 1.4% |
| 27 | REGNREGENERON PHARMCTCLS | 2,869 | $2.2M | 1.4% |
| 28 | SYKSTRYKER CORP | 7,829 | $2.2M | 1.4% |
| 29 | DHRDANAHER CORP | 9,597 | $2.1M | 1.4% |
| 30 | ROIVROIVANT SCIENCES LTD | 58,100 | $2.1M | 1.4% |
| 31 | IMTXIMMATICS NV | 225,985 | $2.0M | 1.3% |
| 32 | TMOTHERMO FISHER SCIENTIFIC | 2,908 | $2.0M | 1.2% |
| 33 | IQVIQVIA HOLDINGS INC | 7,014 | $1.9M | 1.2% |
| 34 | ALNYALNYLAM PHARMACUETCL | 7,385 | $1.8M | 1.2% |
| 35 | ABTABBOTT LABS | 18,080 | $1.8M | 1.1% |
| 36 | TECXTECTONIC THERAPEUTIC | 72,592 | $1.7M | 1.1% |
| 37 | PFEPFIZER INC | 57,500 | $1.6M | 1% |
| 38 | QUREUNIQURE N.V. | 62,425 | $1.5M | 1% |
| 39 | UTHRUNITED THERAPEUTICS | 2,695 | $1.5M | 0.9% |
| 40 | ABVXABIVAX SA | 14,561 | $1.4M | 0.9% |
| 41 | TMDXTRANSMEDICS GROUP INC | 15,950 | $1.3M | 0.8% |
| 42 | PLSEPULSE BIOSCIENCES INC | 26,170 | $1.3M | 0.8% |
| 43 | CVSCVS HEALTH CORP | 13,041 | $1.1M | 0.7% |
| 44 | MRNAMODERNA INC | 5,300 | $1.0M | 0.6% |
| 45 | CYTKCYTOKINETICS INC | 15,289 | $1.0M | 0.6% |
| 46 | MDTMEDTRONIC PLC | 11,100 | $965,811 | 0.6% |
| 47 | VERAVERA THERAPEUTICS | 28,573 | $922,622 | 0.6% |
| 48 | ELVELEVANCE HEALTH INC | 2,006 | $779,973 | 0.5% |
| 49 | BMYBRISTOL MYERS SQUIBB | 12,061 | $752,606 | 0.5% |
| 50 | CNCCENTENE CORP DEL | 12,040 | $747,925 | 0.5% |
| 51 | BSXBOSTON SCIENTIFIC | 14,730 | $642,965 | 0.4% |
| 52 | NKTRNEKTAR THERAPEUTICS | 10,111 | $612,171 | 0.4% |
| 53 | EWEDWARDS LIFESCIENCES | 6,804 | $587,321 | 0.4% |
| 54 | ASNDASCENDIS PHARMA A/S | 2,570 | $585,523 | 0.4% |
| 55 | ILMNILLUMINA INC | 2,132 | $583,486 | 0.4% |
| 56 | BMRNBIOMARIN PHARMAC | 9,450 | $567,000 | 0.4% |
| 57 | RVMDREVOLUTION MEDICINES | 2,760 | $566,518 | 0.4% |
| 58 | PTCTPTC THERAPEUTICS INC | 8,570 | $555,165 | 0.4% |
| 59 | HUMHUMANA INC | 1,255 | $478,870 | 0.3% |
| 60 | RPRXROYALTY PHARMA PLC | 7,200 | $420,192 | 0.3% |
| 61 | BIIBBIOGEN INC | 1,850 | $417,878 | 0.3% |
| 62 | GMABGENMAB A/S | 9,900 | $353,183 | 0.2% |
| 63 | GHGUARDANT HEALTH INC | 1,980 | $353,153 | 0.2% |
| 64 | IONSIONIS PHARMACEUTICAL | 7,200 | $321,480 | 0.2% |
| 65 | TEMTEMPUS AI INC | 3,880 | $317,772 | 0.2% |
| 66 | ORICORIC PHARMACEUTICALS | 23,500 | $316,545 | 0.2% |
| 67 | INCYINCYTE CORPORATION | 2,350 | $285,173 | 0.2% |
| 68 | AXSMAXSOME THERAPEUTIC | 1,500 | $276,585 | 0.2% |
| 69 | NAMSNEWAMSTERDAM PHARMA COMPANY | 9,500 | $231,040 | 0.1% |
| 70 | ARDXARDELYX INC | 56,100 | $191,862 | 0.1% |
| 71 | CRBPCORBUS PHARMACEUTICALS HLDGS | 28,000 | $190,960 | 0.1% |
| 72 | KURAKURA ONCOLOGY INC | 17,050 | $182,606 | 0.1% |
| 73 | SPRYARS PHARMACEUTICALS | 40,300 | $173,693 | 0.1% |
| 74 | NBIXNEUROCRINE BIOSCIENCES | 1,150 | $163,116 | 0.1% |
| 75 | ALXOALX ONCOLOGY HLDGS INC | 90,000 | $125,100 | 0.1% |
| 76 | PALIPALISADE BIO INC | 88,000 | $118,800 | 0.1% |
| 77 | EYPTEYEPOINT INC | 23,700 | $77,499 | 0% |
| 78 | ENGNENGENE THERAPEUTICS INC | 21,700 | $43,400 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.